HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Translational Research: Bridging the gap between laboratory findings and clinical applications.

Translational Research: Bridging the gap between laboratory findings and clinical applications.

Translational research is the bridge between laboratory science and clinical practice, enabling the rapid application of discoveries from the bench to the bedside. It involves converting insights from cancer biology, genetics, and molecular pathways into new diagnostic tools, treatment strategies, and prevention methods that can be tested in clinical trials. Translational research is focused on improving clinical trial design, identifying biomarkers that predict treatment responses, and enhancing patient recruitment strategies to ensure diverse representation in studies. By refining these aspects, translational research accelerates the process of developing innovative, evidence-based treatments that can significantly improve patient outcomes. This approach emphasizes collaboration between researchers, clinicians, and the healthcare system to bring cutting-edge science directly to those in need, driving meaningful improvements in cancer care.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp